about
Fungal recognition enhances mannose receptor shedding through dectin-1 engagementAssociation of MMP-2 polymorphisms with severe and very severe COPD: a case control study of MMPs-1, 9 and 12 in a European population.Survival and disease progression in UK patients with lymphangioleiomyomatosis.Natural history of angiomyolipoma in lymphangioleiomyomatosis: implications for screening and surveillance.Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trialExtra-cellular matrix proteins induce matrix metalloproteinase-1 (MMP-1) activity and increase airway smooth muscle contraction in asthma.The role of inflammation resolution speed in airway smooth muscle mass accumulation in asthma: insight from a theoretical model.Clinical experience of lymphangioleiomyomatosis in the UK.Emerging clinical picture of lymphangioleiomyomatosis.Wild type mesenchymal cells contribute to the lung pathology of lymphangioleiomyomatosisAccelerated extracellular matrix turnover during exacerbations of COPD.Clinical utility of diagnostic guidelines and putative biomarkers in lymphangioleiomyomatosis.Air travel in women with lymphangioleiomyomatosis.Study of breast cancer incidence in patients of lymphangioleiomyomatosis.Secretory leukocyte protease inhibitor gene deletion alters bleomycin-induced lung injury, but not development of pulmonary fibrosis.Tissue and matrix influences on airway smooth muscle function.In search of the fibrotic epithelial cell: opportunities for a collaborative network.Perspectives for improving the evaluation and access of therapies for rare lung diseases in Europe.The role of extracellular matrix quality in pulmonary fibrosis.The International LAM Registry: a component of an innovative web-based clinician, researcher, and patient-driven rare disease research platform.Cathepsin K in Lymphangioleiomyomatosis: LAM Cell-Fibroblast Interactions Enhance Protease Activity by Extracellular Acidification.Discoidin domain receptor 1 regulates bronchial epithelial repair and matrix metalloproteinase production.Role of the CXCR4/CXCL12 axis in lymphangioleiomyomatosis and angiomyolipoma.The economic burden of tuberous sclerosis complex in the UK: A retrospective cohort study in the Clinical Practice Research Datalink.Analysis of the oestrogen response in an angiomyolipoma derived xenograft model.Matrix metalloproteinase expression and activity in human airway smooth muscle cells.A 4-year prospective evaluation of protocols to improve clinical outcomes for patients with lymphangioleiomyomatosis in a national clinical centre.Synthetic functions of airway smooth muscle in asthma.An assay to evaluate the long term effects of inflammatory mediators on airway smooth muscle: evidence that TNF(alpha)up-regulates 5-HT(2A) mediated contraction.Matrix Metalloproteinase-1 Activation Contributes to Airway Smooth Muscle Growth and Asthma Severity.Use of a three-dimensional cell culture model to study airway smooth muscle-mast cell interactions in airway remodeling.Effect of doxycycline on proliferation, MMP production, and adhesion in LAM-related cells.TIMP-1 in asthma: guilty by association.The TSC-2 product tuberin is expressed in lymphangioleiomyomatosis and angiomyolipoma.Presence of a prothrombotic state in people with idiopathic pulmonary fibrosis: a population-based case-control study.Matrix metalloproteinases -8 and -9 in the Airways, Blood and Urine During Exacerbations of COPD.MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis.ECM Crosslinking Enhances Fibroblast Growth and Protects Against Matrix Proteolysis in Lung Fibrosis.Reply to: Treatment of Pulmonary Lymphangioleiomyomatosis During Pregnancy.
P50
Q24609870-E92763D1-EA03-448D-A488-A8F2F9E51201Q33524573-3993C8CB-B990-454C-B807-21DE27D99F9CQ34343897-014B311C-28B4-4400-99FC-D73996D7C104Q34374868-0D4EF210-C0F8-41E6-A7A9-79FA02D5F7B6Q35063739-122F9F78-7895-4BC9-9F8E-127C5954B023Q35109142-4DDD1EDE-F4B5-4642-BC18-68E5F1D28B07Q35121650-7176238E-5C7E-47D1-A36B-AE502280F573Q35533560-4DD714FC-C9AB-4E0D-90A2-A744FD526C33Q35537190-014D437D-467C-437C-810C-A6C00211A20DQ35610828-34BF8DDB-25D7-4142-B7FE-113D480634BCQ35816871-75C96475-B46D-4E34-A306-4AEA59C7B3AAQ36202928-6C21C566-C1A9-4699-ABC4-EB0970CC0F5BQ36203236-ACC018F6-08A9-49EE-AAA9-3CCCE6C987EAQ36678521-61F57174-0E0B-4782-B05B-7583DEC4D28EQ36945415-36CD554B-F444-4B82-8365-AEAD700701A4Q37365836-2E8C9187-B627-43C7-9124-62E77F4AAC86Q37890719-63C7250B-A672-471A-B1C3-2D521785F791Q37993295-6076BB6F-4EC4-4312-B971-83DB0FD9F4D1Q38264047-AE8C7FA2-D8CE-4E59-AEE4-FAE5634F50BEQ38431083-3C54154D-7158-42A5-8468-22E957A6BFDEQ38700054-18D4D466-C423-492C-A200-B8A29204E933Q39649400-6424007F-F56C-4CA7-9130-34C22E20671FQ39687406-347E665F-DBC1-48C5-8303-618E9621BABDQ39706758-3D858F9E-CEE3-421F-A207-5CEB1C43F55DQ39920532-24557606-B211-49CF-8C06-C93A6DA31055Q40533202-28205AC5-62E2-4689-8730-B4AF5C4CA35CQ40784100-A6E9B37D-63A1-4FA8-936E-5B2A8E01848AQ40885496-D159D1DA-D4C2-41E3-9507-D62DD9674B6CQ41858900-BFD6E9C5-F7EC-4347-848C-495F3196569EQ42283718-2B79EEC8-FE6B-4550-8968-7EABF5DA8C11Q42451819-F8163632-90B0-4832-A1CB-94A46357F2A9Q43004342-66BB4B93-8C79-49EF-BF67-EB02356BD6B4Q43058563-FE638CFB-E0A1-4C54-B499-F56A17B03119Q43993276-7F90FE3F-AB27-4706-BD20-8F2F5A9D427CQ46345217-5D65FAB7-29C2-4B82-8928-62262D869D33Q46662378-258A0F30-5E53-4946-ACDD-8A7D3EB08067Q46712062-B9C45D92-E4F3-4B6F-B62B-2F10835EB1DEQ46815548-ABC2AE78-5508-46DF-B4BC-D552BAF714E6Q47624484-692A67EA-63E4-4583-B568-8160E2113DBCQ47642680-16D26943-2430-430D-8EC7-2E24B96E0932
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Simon R Johnson
@nl
Simon R Johnson
@sl
Simon R. Johnson
@en
Simon R. Johnson
@es
type
label
Simon R Johnson
@nl
Simon R Johnson
@sl
Simon R. Johnson
@en
Simon R. Johnson
@es
prefLabel
Simon R Johnson
@nl
Simon R Johnson
@sl
Simon R. Johnson
@en
Simon R. Johnson
@es
P106
P1153
7406327608
P21
P31
P496
0000-0002-9837-2763